332 related articles for article (PubMed ID: 24403249)
21. Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells.
Wang F; Zhang L; Liu J; Zhang J; Xu G
Aging (Albany NY); 2020 Jun; 12(11):11042-11060. PubMed ID: 32516753
[TBL] [Abstract][Full Text] [Related]
22. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
[No Abstract] [Full Text] [Related]
23. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.
Alvero AB; Chen R; Fu HH; Montagna M; Schwartz PE; Rutherford T; Silasi DA; Steffensen KD; Waldstrom M; Visintin I; Mor G
Cell Cycle; 2009 Jan; 8(1):158-66. PubMed ID: 19158483
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
Lee YY; Jeon HK; Hong JE; Cho YJ; Ryu JY; Choi JJ; Lee SH; Yoon G; Kim WY; Do IG; Kim MK; Kim TJ; Choi CH; Lee JW; Bae DS; Kim BG
Oncotarget; 2015 Oct; 6(33):35040-50. PubMed ID: 26418900
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of MyD88 expression by human epithelial ovarian carcinoma cells.
Zhu Y; Huang JM; Zhang GN; Zha X; Deng BF
J Transl Med; 2012 Apr; 10():77. PubMed ID: 22533866
[TBL] [Abstract][Full Text] [Related]
26. Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm.
Garson K; Vanderhyden BC
Reproduction; 2015 Feb; 149(2):R59-70. PubMed ID: 25301968
[TBL] [Abstract][Full Text] [Related]
27. The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer.
Bates M; Spillane CD; Gallagher MF; McCann A; Martin C; Blackshields G; Keegan H; Gubbins L; Brooks R; Brooks D; Selemidis S; O'Toole S; O'Leary JJ
PLoS One; 2020; 15(12):e0243715. PubMed ID: 33370338
[TBL] [Abstract][Full Text] [Related]
28. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
[TBL] [Abstract][Full Text] [Related]
29. Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma.
Gurler H; Yu Y; Choi J; Kajdacsy-Balla AA; Barbolina MV
Int J Mol Sci; 2015 Feb; 16(2):3419-33. PubMed ID: 25658796
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer.
Chen H; Lee LJ; Vincent KM; Xu Z; Liu J; Zhang G; Nakevska Z; Smith D; Lee CH; Postovit LM; Fu Y
Oncogene; 2024 May; 43(22):1688-1700. PubMed ID: 38594503
[TBL] [Abstract][Full Text] [Related]
31. MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.
Silasi DA; Alvero AB; Illuzzi J; Kelly M; Chen R; Fu HH; Schwartz P; Rutherford T; Azodi M; Mor G
Yale J Biol Med; 2006 Dec; 79(3-4):153-63. PubMed ID: 17940625
[TBL] [Abstract][Full Text] [Related]
32. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
33. Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma.
Han HD; Cho YJ; Cho SK; Byeon Y; Jeon HN; Kim HS; Kim BG; Bae DS; Lopez-Berestein G; Sood AK; Shin BC; Park YM; Lee JW
Mol Cancer Ther; 2016 Apr; 15(4):618-27. PubMed ID: 26861249
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
[TBL] [Abstract][Full Text] [Related]
35. Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429.
Guo Q; Lu L; Liao Y; Wang X; Zhang Y; Liu Y; Huang S; Sun H; Li Z; Zhao L
Cell Death Dis; 2018 Jan; 8(1):e3178. PubMed ID: 29324735
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.
Auzenne E; Ghosh SC; Khodadadian M; Rivera B; Farquhar D; Price RE; Ravoori M; Kundra V; Freedman RS; Klostergaard J
Neoplasia; 2007 Jun; 9(6):479-86. PubMed ID: 17603630
[TBL] [Abstract][Full Text] [Related]
37. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
38. KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer.
Wu X; Qiu L; Feng H; Zhang H; Yu H; Du Y; Wu H; Zhu S; Ruan Y; Jiang H
Life Sci; 2022 Mar; 293():120328. PubMed ID: 35051418
[TBL] [Abstract][Full Text] [Related]
39. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2.
Xia B; Lin M; Dong W; Chen H; Li B; Zhang X; Hou Y; Lou G
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22168. PubMed ID: 30004169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
